GlassScriptPhysician profile
Jason Welch
NPI 1952317893
$767.28
in general payments reported to CMS, 2019-2025
19 companies · $41.57 in 2025
The $41.57 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $77.32 · 2023: $316 · 2024: $332 · 2025: $41.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $205.76 | 2022-2024 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $105.12 | 2023-2025 | Ubrelvy, Qulipta |
| Astrazeneca Pharmaceuticals LP | $67.34 | 2022-2024 | Airsupra, Farxiga |
| Corium, LLC | $59.46 | 2023 | Azstarys, Adlarity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.60 | 2023-2025 | Xifaxan |
| Lilly USA, LLC | $40.87 | 2022-2023 | Mounjaro, Trulicity, Jardiance |
| Dynavax Technologies Corporation | $34.75 | 2023-2024 | Heplisav-B |
| Lundbeck LLC | $27.89 | 2023 | Rexulti |
| Pfizer INC. | $19.32 | 2023 | |
| Phathom Pharmaceuticals, INC. | $18.98 | 2024 | Voquezna |
| Exact Sciences Corporation | $18.95 | 2024 | Cologuard Collection Kit |
| Almatica Pharma LLC | $18.90 | 2022 | |
| Sunovion Pharmaceuticals INC. | $17.64 | 2022 | |
| Sumitomo Pharma America, INC. | $17.29 | 2023 | Gemtesa |
| Esperion Therapeutics, INC. | $15.33 | 2024 | Nexletol |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.10 | 2023 | Prolia, Evenity |
| Janssen Pharmaceuticals, INC | $14.91 | 2023 | Xarelto |
| Edwards Lifesciences Corporation | $14.09 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Glaxosmithkline, LLC. | $12.98 | 2023 | Arexvy, Shingrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Welch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.